During the past decade, COR Healthcare conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 1 clinical trials were completed, i.e. on average, 20% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "COR Healthcare" are "Heart Failure" (5 trials), "Optim Lead Insulation Related Adverse Events" (1 trials) and "Ventricular Tachycardia" (1 trials). Many other conditions were trialed in "COR Healthcare" in a lesser frequency.

Most popular intervention types in "COR Healthcare" are "Device" (4 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "BiV/MPP" (1 trials), "Cardiac Resynchronization Therapy - MPP" (1 trials), "Intrinsic Antitachycardia Pacing (iATP) Therapy" (1 trials), "MPP" (1 trials) and "Observational" (1 trials). Other intervention names were less common.

The vast majority of trials in "COR Healthcare" are 7 trials for "All" genders.

Currently, there are NaN active trials in "COR Healthcare". undefined are not yet recruiting, 3 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in COR Healthcare, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in COR Healthcare, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".